866-997-4948(US-Canada Toll Free)

Non Malignant pain Global Clinical Trials Review, H2, 2015

Published By :

GlobalData

Published Date : Dec 2015

Category :

Pharmaceutical

No. of Pages : 68 Pages

Non Malignant pain Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, Non Malignant pain Global Clinical Trials Review, H2, 2015" provides an overview of Non Malignant pain clinical trials scenario. This report provides top line data relating to the clinical trials on Non Malignant pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Non Malignant pain to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Non Malignant pain to Central Nervous System Clinical Trials 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Non Malignant pain Therapeutics Clinical Trials 27
Prominent Drugs 29
Clinical Trial Profile Snapshots 30
Appendix 65
Abbreviations 65
Definitions 65
Research Methodology 66
Secondary Research 66
About GlobalData 67
Contact Us 67
Disclaimer 67
Source 68

List of Tables
Non Malignant pain Therapeutics, Global, Clinical Trials by Region, 2015* 6
Non Malignant pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Non Malignant pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Non Malignant pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Non Malignant pain Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Non Malignant pain Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Non Malignant pain Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Non Malignant pain Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Non Malignant pain to Central Nervous System Clinical Trials, G7 Countries (%), 2015* 15
Non Malignant pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Non Malignant pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Non Malignant pain to Central Nervous System Clinical Trials, E7 Countries (%), 2015* 18
Non Malignant pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Non Malignant pain Therapeutics, Global, Clinical Trials by Phase, 2015* 20
Non Malignant pain Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 21
Non Malignant pain Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Non Malignant pain Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Non Malignant pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 24
Non Malignant pain Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 25
Non Malignant pain Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 26
Non Malignant pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28
Non Malignant pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 29

List of Figures
Non Malignant pain Therapeutics, Global, Clinical Trials by Region (%), 2015* 6
Non Malignant pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Non Malignant pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Non Malignant pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Non Malignant pain Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Non Malignant pain Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Non Malignant pain Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Non Malignant pain Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Non Malignant pain to Central Nervous System Clinical Trials, G7 Countries (%), 2015* 15
Non Malignant pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Non Malignant pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Non Malignant pain to Central Nervous System Clinical Trials, E7 Countries (%), 2015* 18
Non Malignant pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Non Malignant pain Therapeutics, Global, Clinical Trials by Phase (%), 2015* 20
Non Malignant pain Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 21
Non Malignant pain Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Non Malignant pain Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Non Malignant pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 24
Non Malignant pain Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 25
Non Malignant pain Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 26
Non Malignant pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 27
Non Malignant pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 29
GlobalData Methodology 66

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *

Upcoming Reports

  • Endobronchial Cancer Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

    Endobronchial cancer are characterized by small size, slow growth and usually misdiagnosed as asthma or chronic bronchitis due to their common symptoms. These cancers are usually benign and rare. Due to these reasons, they may remain undiagnosed for a long time and lead to serious complications. The term bronchial adenoma encompasses a diverse group of tumors of mucous glands, trachea or bronchi. Common symptoms of endobronchial cancer include ...

  • Sufentanil Citrate Market - Global Industry Analysis, Size, Share, Trends and Forecast 2014 - 2020

    Sufentanil citrate is a synthetic analgesic drug and primarily finds its application in inducing anesthesia during surgery. Sufentanil citrate is also used as epidural anesthesia during labor and delivery along with various other medicines.  Sufentanil citrate is typically white in color and used in powdered form.  Sufentanil citrate demonstrates high solubility in both water as well as alcohol. Sufentanil citrate is 2000 to 4000 ...

  • Grass Pollen Allergy Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

    Pollens are made up of tiny particles released by trees, plants and grasses during spring and summer as part of their reproductive cycle. Pollen owing to its fine particles can be easily inhaled by humans and animals which can cause significant irritation and inflammation to some people. Allergic rhinitis or hay fever is among the most common form of allergy caused by grass pollen. According to a study conducted by American College of Allergy, ...